Cargando…
A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus
BACKGROUND: Mycobacterium abscessus is a rapidly growing mycobacteria involved in severe infections of the lung, skin, or soft tissue. Macrolides such as clarithromycin are the recommended first line drugs for treatment of M. abscessus infections. However, M. abscessus has dual mechanisms of resista...
Autores principales: | Sharma, Meenu Kaushal, La, Yanni, Janella, Debra, Soualhine, Hafid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730737/ https://www.ncbi.nlm.nih.gov/pubmed/33302900 http://dx.doi.org/10.1186/s12879-020-05686-0 |
Ejemplares similares
-
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex
por: Rubio, Marc, et al.
Publicado: (2015) -
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021) -
Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017) -
The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin
por: Vianna, Júlia S., et al.
Publicado: (2019) -
Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish
por: Goh, Boon Chong, et al.
Publicado: (2023)